natgillin/translations-raw huggingface dataset:
The vaccine is given to puppies from six weeks of age as an injection, under the skin, and repeated three to four weeks later.
Cjepivo se primjenjuje u štenadi u dobi od šest tjedana u obliku supkutane injekcije i ponavlja se nakon tri do četiri tjedana.
The vaccine is given to rabbits from 30 days of age as a single injection under the skin of the side of the chest.
Cjepivo se daje kunićima starijima od 30 dana putem jedne injekcije koja se daje ispod kože s bočne strane prsa.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus type 1 and 2, canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola servar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Cjepivo je namijenjeno aktivnoj imunizaciji zdrave štenadi i zdravih pasa protiv bolesti koje uzrokuje virus štenećaka, pseći parvovirus, pseći adenovirus tip 1 i tip 2, pseći virus parainfluence, Leptospira interrogans serotip Australis serovar Bratislava, Leptospira interrogans serotip Canicola serovar Canicola, Leptospira kirschneri serotip Grippotyphosa serovar Grippotyphosa i Leptospira interrogans serotip Icterohaemorrhagiae serovar Icterohaemorrhagiae.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus type 1 and 2, canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola servar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa, Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie, and rabies virus.
Cjepivo je namijenjeno aktivnoj imunizaciji zdrave štenadi i zdravih pasa protiv bolesti koje uzrokuju: virus štenećaka, pseći parvovirus, pseći adenovirus tip 1 i tip 2, pseći virus parainfluence, Leptospira kirschneri serotip Australis serovar Bratislava, Leptospira interrogans serotip Canicola serovar Canicola, Leptospira interrogans serotip Grippotyphosa serovar Grippotyphosa i Leptospira interrogans serotip Icterohaemorrhagiae serovar Icterohaemorrhagiae i virus bjesnoće.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine parainfluenza virus, Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola serovar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Cjepivo je namijenjeno aktivnoj imunizaciji zdrave štenadi i zdravih pasa protiv bolesti koje uzrokuje pseći virus parainfluence, Leptospira interrogans, serotip Australis, serovar Bratislava, Leptospira interrogans, serotip Canicola, serovar Canicola, Leptospira kirschneri, serotip Grippotyphosa, serovar Grippotyphosa, i Leptospira interrogans, serotip Icterohaemorrhagiae, serovar Icterohaemorrhagaie.
The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by Leptospira interrogans serogroup Australis serovar Bratislava, Leptospira interrogans serogroup Canicola serovar Canicola, Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa and Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagaie.
Cjepivo je namijenjeno aktivnoj imunizaciji zdrave štenadi i zdravih pasa protiv bolesti koje uzrokuje pseći virus parainfluence, Leptospira interrogans, serotip Australis, serovar Bratislava, Leptospira interrogans, serotip Canicola, serovar Canicola, Leptospira kirschneri, serotip Grippotyphosa serovar, Grippotyphosa i Leptospira interrogans, serotip Icterohaemorrhagiae, serovar Icterohaemorrhagaie.
The vaccine is intended for use in horses for which a risk of Streptococcus equi infection has been clearly identified, due to contact with horses from areas where this pathogen is known to be present, e.g. stables with horses that travel to shows and/or competitions in such areas, or stables that obtain or have livery horses from such areas.
Vakcina je namijenjena za primjenu u konja kod kojih je rizik od infekcije sa Streptococcus equi jasno identificiran zbog kontakta s konjima s područja gdje je prisutna bakterija, npr. staje s konjima koji putuju na predstave i/ili natjecanja u takva područja ili staje koje dobivaju ili se opskrbljuju s hranom za konje iz takvih područja.
The vaccine is made using an ‘adjuvant system’ that contains MPL, a purified lipid (a fat-like substance) extracted from bacteria, which enhances the response of the immune system to the vaccine.
Cjepivo se proizvodi pomoću „adjuvansnog sustava” koji sadrži MPL, pročišćeni lipid (tvar sličnu masti) ekstrahiran iz bakterije, što pojačava odgovor imunosnog sustava na cjepivo.
The vaccine is not intended for birds in lay.
Cjepivo nije namijenjeno za ptice koje nesu.
The vaccine is ready to use (no reconstitution or dilution is required).
Cjepivo je spremno za primjenu (nije potrebna rekonstitucija ni razrjeđivanje).
The vaccine is reconstituted by adding the contents of the vial containing the DTPa-HBV-IPV suspension by means of a syringe to the vial containing the powder.
Cjepivo se rekonstituira dodavanjem cjelokupnog sadržaja bočice s DTPa-HBV-IPV suspenzijom pomoću štrcaljke u bočicu koja sadržava prašak.
The vaccine is reconstituted by adding the entire contents of the vial containing the DTPa-HBV-IPV suspension by means of a syringe to the vial containing the powder.
Cjepivo se rekonstituira dodavanjem cjelokupnog sadržaja bočice s komponentom DTPa-HBV-IPV pomoću štrcaljke u bočicu koja sadržava prašak.
The vaccine is safe in infected dogs.
Cjepivo je sigurno za neinficirane pse.
The vaccine is supplied in type I (Ph.
Vakcina je pakovana u Tip I (Ph.
The vaccine is to be injected intramuscularly (IM) or subcutaneously (SC).
Cjepivo treba injicirati intramuskularno (i.m.) ili supkutano (s.c.).
The vaccine is used to reduce the number of horses with the West Nile virus lineage 1 or 2 in their blood (viraemia) and to reduce the severity and duration of clinical signs of West Nile virus disease caused by lineage 2 strains.
Cjepivo se koristi za smanjivanje broja (viremičnih) konja nakon infekcije virusom Zapadnog Nila linije sojeva 1 ili 2 u krvi i da bi se smanjila težina i trajanje kliničkih znakova bolesti virusa Zapadnog Nila uzrokovane linijama sojeva 2.
The vaccine is ‘adsorbed’ on aluminium compounds.
Cjepivo je „adsorbirano” na aluminijske spojeve.
The vaccine is ‘adsorbed’, which means that the virus-like particles and the MPL are fixed onto an aluminium compound, to stimulate a better immune response.
Cjepivo se „adsorbira”, što znači da se čestice slične virusu i MPL pričvršćuju na aluminijev spoj kako bi se stimulirao bolji imunosni odgovor.
The vaccine is ‘adsorbed’.
Cjepivo je „adsorbirano”.
The vaccine may be applied by an automatic syringe.
Cjepivo se može injektirati automatskom špricom.
The vaccine may contain traces of glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin B which are used during the manufacturing process (see section 4.3).
Cjepivo može sadržavati tragove glutaraldehida, formaldehida, neomicina, streptomicina i polimiksina B koji su korišteni u proizvodnom procesu (vidjeti dio 4.3).
The vaccine protects adults and children from 2 years of age against cholera.
Cjepivo štiti odrasle i djecu u dobi od 2 godine nadalje od kolere.
The vaccine provides protection only against RHDV2, cross protection against classical RHDV has not been demonstrated.
Cjepivo pruža zaštitu samo protiv RHDV2, unakrsna zaštita protiv klasičnog virusa RHDV nije utvrđena.
The vaccine response was defined as the proportion of subjects with: rSBA titres  32 for initially seronegative subjects (i.e., pre-vaccination rSBA titre < 8) at least a 4-fold increase in rSBA titres from pre- to post-vaccination for initially seropositive subjects (i.e., pre-vaccination rSBA titre ≥ 8)
Odgovor na cjepivo je definiran kao udio ispitanika s: rSBA titrima ≥ 32 za inicijalno seronegativne ispitanike (tj. rSBA titar < 8 prije cijepljenja) najmanje četverostrukim porastom rSBA titra od onog prije do onog nakon cijepljenja za inicijalno seropozitivne ispitanike (tj. rSBA titar ≥ 8 prije cijepljenja)
The vaccine should be administered in accordance with the recommended posology (see section 3 “How Adjupanrix is given”).
Cjepivo se treba primijeniti sukladno preporučenom doziranju (vidjeti dio 3 „ Kako primjenjivati Adjupanrix“).
The vaccine should be administered in accordance with the recommended posology (see section 3 “How Prepandrix is given”).
Cjepivo treba primjenjivati sukladno preporučenom doziranju (vidjeti dio 3 "Kako se primjenjuje Prepandrix").
The vaccine should be administered in accordance with the recommended posology (see section 4.2).
Cjepivo se treba davati sukladno preporučenom doziranju (vidjeti dio 4.2).
The vaccine should be allowed to reach room temperature before use.
Cjepivo treba doseći sobnu temperaturu prije primjene.
The vaccine should be allowed to reach room temperature before use.
Cjepivo treba ostaviti da dostigne sobnu temperaturu prije uporabe.
The vaccine should be allowed to reach room temperature before use.
Prije primjene cjepivo treba ostaviti da dosegne sobnu temperaturu.
The vaccine should be allowed to reach room temperature before use.
Prije primjene cjepivo treba ostaviti da dostigne sobnu temperaturu.
The vaccine should be allowed to reach room temperature before use.
Prije primjene, cjepivo treba ostaviti da dosegne sobnu temperaturu.
The vaccine should be allowed to reach room temperature before use.
Prije primjene, cjepivo treba pustiti da dosegne sobnu temperaturu.
The vaccine should be allowed to reach room temperature before use.
Prije uporabe treba pričekati da cjepivo dosegne sobnu temperaturu.
The vaccine should be inspected visually for any foreign particulate matter and/or abnormal physical appearance.
Cjepivo treba vizualno provjeriti kako bi se uočile eventualne strane čestice i/ili neuobičajeni izgled prije primjene.
The vaccine should be inspected visually prior to administration for any foreign particulate matter and/or abnormal physical appearance.
Prije primjene cjepivo je potrebno pregledati zbog stranih čestica i/ili neprirodnog fizičkog izgleda.
The vaccine should be used as supplied.
Cjepivo treba primijeniti u dostavljenom obliku.
The vaccine should be used immediately after opening.
Cjepivo treba primijeniti odmah nakon otvaranja.
The vaccine should be well shaken to obtain a homogeneous white suspension and be inspected visually for any particulate matter and/or variation of physical aspect prior to administration.
Cjepivo treba dobro protresti prije primjene da bi se dobila homogena suspenzija bijele boje i treba ga vizualno pregledati da ne sadrži čestice i/ili da nema promjene u fizičkom izgledu.
The vaccine should be well shaken to obtain a slightly opaque, white suspension and visually inspected for any foreign particulate matter and/or abnormal physical appearance prior to administration.
Prije primjene cjepivo treba dobro protresti kako bi se dobila lagano zamućena bijela suspenzija, te vizualno provjeriti na prisutnost bilo kakvih stranih čestica i/ili promjenu fizičkog izgleda.
The vaccine should be well shaken to obtain a slightly opaque, white suspension and visually inspected for any foreign particulate matter and/or variation of physical aspect prior to administration.
Prije primjene cjepivo treba dobro protresti kako bi se dobila lagano zamućena bijela suspenzija, te vizualno provjeriti na prisutnost bilo kakvih stranih čestica i/ili promjenu fizičkog izgleda.
The vaccine should never be given into a blood vessel or into the skin.
Cjepivo se nikada ne smije primijeniti u krvnu žilu ili u kožu.
The vaccine should never be given into a blood vessel.
Cjepivo se nikada ne smije primijeniti u krvnu žilu.
The vaccine should never be given into a vein.
Cjepivo se nikad ne smije primijeniti u krvnu žilu.
The vaccine should not be administered intravascularly.
Cjepivo se ne smije primjenjivati u krvnu žilu.
The vaccine should not be given (deep) into the skin or intramuscularly into the buttock because protection may be less.
Cjepivo se ne smije dati (duboko) u kožu ili intramuskularno u mišić stražnjice zbog moguće umanjene zaštite.
The vaccine should not be used if foreign particles are present in the suspension.
Cjepivo se ne smije primijeniti ukoliko su u suspenziji prisutne strane čestice.
The vaccine should preferably be dissolved in distilled water or alternatively in cool, clean water.
Cjepivo je bolje topiti u destiliranoj vodi ili u hladnoj, čistoj vodi.
The vaccine stimulates active immunity against porcine circovirus type 2 and Mycoplasma hyopneumoniae in pigs.
Cjepivo stimulira aktivnu imunost protiv cirko virus svinja tip2 i Mycoplasma hyopneumoniae kod svinja.
The vaccine strain can be detected in respiratory tract of the chickens until 55 weeks after vaccination.
Cjepni soj može se detektirati u respiratornom traktu pilića sve do 55 tjedana nakon cijepljenja.
The vaccine strain can be found in the spleen for at least 35 days.
Vakcinalni soj može biti prisutan u slezeni kroz najmanje 35 dana.
The vaccine strain can be identified by its growth properties on biological growth media: it shows normal growth on MacConkey and trypticase soy agar, while no colonies are observed when plated without aromatic amino acids (minimum agar).
Vakcinalni soj se može identificirati prema svojim značajkama rasta na biološkim hranjivim medijima: pokazuje normalan rast na MacConkey i tripton soja agaru, dok kolonije nisu opažene kada je nasađen bez aromatskih aminokiselina (minimalni agar).
The vaccine strain can be identified by its growth properties on biological growth media: it shows normal growth on MacConkey and trypticase soy agar, while no colonies are observed when plated without aromatic amino acids (minimum agar).
Vakcinalni soj se može identificirati prema značajkama rasta na biološkim hranjivim medijima: pokazuje normalan rast na MacConkey i tripton soja agaru, dok kolonije nisu opažene kada je nasađen bez aromatskih aminokiselina (minimalni agar).
The vaccine strain can spread from vaccinated to unvaccinated birds, including wild species.
Cjepni soj može prijeći sa cijepljenih na necijepljene ptice, uključujući i divlje vrste.
The vaccine strain is a myxoma virus expressing the capsid protein gene of rabbit haemorrhagic disease virus.
Cjepni soj je miksoma virus, koji sadrži gen za kapsidni protein virusa hemoragične bolesti. kunića.
The vaccine strain is a recombinant Herpesvirus of turkeys (HVT) expressing the protective antigen (VP2) of the Infectious Bursal Disease Virus (IBDV) strain Faragher 52/70.
Cjepni soj je rekombinantni virus herpesa purana (HVT) koji izražava zaštitni antigen (VP2) virusa zarazne bolesti burze (IBDV) soj Faragher 52/70.
The vaccine strain is an inactivated recombinant Porcine Circovirus type 1 expressing the Porcine Circovirus type 2 ORF2 protein.
Vakcinalni soj je inaktivirani rekombinirani cirkovirus svinja tip 1 izražen cirkovirusom svinja tip 2, ORF2 protein.
The vaccine strain may spread to in-contact birds.
Vakcinalni soj se može raširiti među peradi u kontaktu.
The vaccine strain readily spreads to other pigs in contact to vaccinated pigs.
Cjepni soj se lako širi na druge svinje u kontaktu sa cijepljenim svinjama.
The vaccine strain vCP1338 is a recombinant canarypox virus expressing feline interleukin-2 (IL-2).
Cjepni soj vCP1338 rekombinantni je virus kanarinskih boginja koji se eksprimira u mačjem interleukinu-2 (IL-2).
The vaccine strain vCP65 is a recombinant Canarypox virus expressing the glycoprotein G gene of rabies virus.
Cijepni soj vCP65 je rekombinirani virus boginja kanarinca koji izražava glikoprotein G gen od virusa bjesnoće.
The vaccine strains are able to infect sheep and swine when administered intranasally, but no adverse reactions or spreading to in-contact animals has been demonstrated.
Sojevi cjepiva u mogućnosti su zaraziti ovcu i svinju kada se primjenjuju intranazalno ali nisu dokazane nuspojave ili širenje virusa na životinje u kontaktu sa zaraženom životinjom.
The vaccine strains are able to infect sheep and swine when administered intranasally, but no adverse reactions or spreading to in-contact animals occurred.
Sojevi cjepiva u mogućnosti su zaraziti ovcu i svinju kada se primjenjuju intranazalno ali nisu dokazane nuspojave ili širenje virusa na životinje u kontaktu sa zaraženom životinjom.
The vaccine strains vCP2242 and vCP3011 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/eq/Ohio/03 (American strain, Florida sublineage clade 1) and A/eq/Richmond/1/07 (American strain, Florida sublineage clade 2), respectively.
Sojevi cjepiva vCP2242 i vCP3011su rekombinanti virusa boginja kanarinca koji iz sojeva virusa konjske gripe A/eq/Ohio/03 (američki soj, Florida podlinija „clade 1“) odnosno A/eq/Richmond/1/07 (američki soj, Florida podlinija „clade 2“)izražavaju gen hemaglutinin HA.
The vaccine strains vCP2242 and vCP3011 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/eq/Ohio/03 (American strain, Florida sublineage clade 1) and A/eq/Richmond/1/07 (American strain, Florida sublineage clade2), respectively.
Sojevi cjepiva vCP2242 i vCP3011su rekombinanti virusa boginja kanarinca koji iz sojeva virusa influence konja A/eq/Ohio/03 (američki soj, Florida podlinija „clade 1“) i A/eq/Richmond/1/07 (američki soj, Florida podlinija „clade 2“) izražavaju gen hemaglutinin HA.
The vaccine suspension is filled in a volume of 3 ml in bottles (type I glass) with a rubber stopper (bromobutyl rubber) and a screw cap.
Suspenzija cjepiva puni se u volumenu od 3 ml u boce (staklo tip I) s gumenim čepom (bromobutil guma) i zatvaračem s navojem.
The vaccine suspension should be inspected visually before and after reconstitution for any foreign particule matter and/or abnormal physical appearance.
Suspenziju cjepiva treba prije i nakon rekonstitucije vizualno pregledati kako bi se utvrdila moguća prisutnost stranih čestica i/ili neuobičajen izgled cjepiva.
The vaccine suspension should be spread evenly over the correct number of chickens, at a distance of 30–40 cm using a coarse spray, preferably when the chickens are sitting together in dim light.
Suspenziju cjepiva treba pomoću raspršivača, s većim kapljicama, ravnomjerno raspršiti po točnom broju pilića, s udaljenosti od 30-40 cm, po mogućnosti, kada su pilići zajedno okupljeni pri prigušenom svjetlu.
The vaccine suspension should then be mixed with the buffer solution and drunk within 2 hours.
Suspenziju cjepiva treba zatim pomiješati s puferskom otopinom i popiti unutar 2 sata.
The vaccine virus may spread from vaccinated to non-vaccinated chickens and appropriate care should be taken to separate vaccinated from non-vaccinated.
Cjepni virus se može širiti s cijepljenih na necijepljene piliće pa treba razdvojiti cijepljene od necijepljenih pilića.
The vaccine virus strain CPV-2b has not been tested in domestic cats and other carnivores (except dogs) that are known to be susceptible to canine parvoviruses.
Cjepni soj CPV-2b nije testiran na mačkama i drugim mesožderima (osim pasa) koji su osjetljivi na pseće parvoviruse.
The vaccine virus strain CPV-2b has not been tested in domestic cats and other carnivores (except dogs) that are known to be susceptible to canine parvoviruses.
Cjepni virus soja CPV-2b nije testiran na domaćim mačkama i ostalim mesojedima (osim pasa) za koje se zna da su osjetljivi na pseći parvovirus.
The vaccine was assessed in 2-dose and 3-dose priming schedules, including the schedule for the Expanded Program on Immunisation, and as a booster dose.
Cjepivo se ocjenjivalo u 2-doznim i 3-doznim rasporedima primarnog cijepljenja, uključujući cijepljenje prema Proširenom programu imunizacije, te kao doza docjepljivanja.
The vaccine will be given by gently squeezing the tube and delivering the vaccine into your child’s mouth.
Cjepivo će se dati laganim pritiskanjem tube i istiskivanjem cjepiva u djetetova usta.
The vaccine will not prevent infection caused by other agents such as hepatitis C and hepatitis E and other pathogens known to infect the liver.
Cjepivo neće spriječiti zarazu uzrokovanu drugim uzročnicima poput virusa hepatitisa C, hepatitisa E ili drugih poznatih patogena koji inficiraju stanice jetre.
The vaccine works by helping the body to make its own antibodies, which protect your child against these diseases.
Cjepivo djeluje tako što pomaže Vašem djetetu da stvori vlastita protutijela koja ga štite od ovih bolesti.
The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person.
Cjepivo djeluje tako da specifično stimulira prirodni tjelesni obrambeni sustav cijepljene osobe.
The vaccines contains 5 micrograms thiomersal (see section 4.4).
Cjepivo sadrži 5 mikrograma tiomersala (vidjeti dio 4.4).
The vaccine’s effectiveness was assessed in one main study involving 2,654 adults, around half of whom were elderly (over 60 years of age).
Djelotvornost cjepiva procijenjena je u jednom glavnom ispitivanju koje je obuhvatilo 2 654 odraslih osoba, od kojih je otprilike polovica bila starije dobi (stariji od 60 godina).
The vacuum will draw the solvent into the ADVATE powder vial (Fig. c).
Otapalo će zbog vakuma prijeći u bočicu s praškom ADVATE (slika c).
The validity of extrapolating these non-clinical data to humans is unknown.
Nije poznato vrijedi li ekstrapolacija ovih nekliničkih podatka na ljude .
The validity of extrapolating these non-clinical data to humans is unknown.
Nije poznato vrijedi li ekstrapolacija ovih nekliničkih podatka na ljude.
The value of biomarkers to predict the efficacy of nivolumab should be further explored, specifically:
Potrebno je dodatno istražiti vrijednost bioloških biljega u predviđanju djelotvornosti nivolumaba, osobito:
The values for the sensitivity of DaTSCAN in determining probable DLB from non-DLB ranged from 75.0% to 80.2% and specificity from 88.6% to 91.4%.
Osjetljivost DaTSCAN-a u određivanju vjerojatnosti DLT-a ili ne-DLT-a bile su u rasponu od 75,0% do 80,2% a specifičnost od 88,6% do 91,4%.
The values tended to stabilize early in the study and did not increase further with continued treatment.
Vrijednosti su bile sklone stabilizaciji u ranoj fazi ispitivanja i nisu se dalje povećavale u nastavku liječenja.
the valve should be fully open when used but not be opened with violence a defective valve should neither be used nor be repaired.
tijekom upotrebe ventil mora biti u potpunosti otvoren, ali se ne smije otvarati na silu neispravan ventil ne smije se upotrebljavati niti popravljati.
The variety (serotype) of the virus in the vaccine is selected depending on which serotypes are circulating and causing disease at the time of manufacture, so it may contain serotype 1, 4 or 8 or a combination of any two of these.
Odabir serotipa virusa u cjepivu ovisi o tome koji serotipovi cirkuliraju i uzrokuju bolest u vrijeme proizvodnje lijeka i stoga cjepivo može sadržavati serotipove 1, 4 ili 8 ili kombinaciju bilo koja dva od tih serotipova.
The vast majority of infliximab cases have occurred in patients with Crohn’s disease or ulcerative colitis and most were reported in adolescent or young adult males.
Kod primjene infliksimaba velika većina ovakvih slučajeva dogodila se u bolesnika s Crohnovom bolešću ili ulceroznim kolitisom i to najviše u adolescenata ili mlađih odraslih muškaraca.
The vast majority of infliximab cases have occurred in patients with Crohn’s disease or ulcerative colitis and most were reported in adolescent or young adult males.
Velika većina ovih slučajeva među bolesnicima liječenim infliksimabom pojavila se u bolesnika s Crohnovom bolešću ili ulceroznim kolitisom a većinom su prijavljeni u adolescenata ili mlađih odraslih muškaraca.